MOONLAKE IMMUNOTHERAPEUTICSMOONLAKE IMMUNOTHERAPEUTICSMOONLAKE IMMUNOTHERAPEUTICS

MOONLAKE IMMUNOTHERAPEUTICS

No trades
See on Supercharts

Price target

1,557.490.000.00%
The 13 analysts offering 1 year price forecasts for MLTX/N have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to MLTX/N in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MLTX/N EPS for the last quarter is −11.03 MXN despite the estimation of −8.58 MXN. In the next quarter EPS is expected to reach −12.19 MXN. Track more of MOONLAKE IMMUNOTHERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter MOONLAKE IMMUNOTHERAPEUTICS revenue is expected to reach 0.00 MXN. Check out MOONLAKE IMMUNOTHERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, MLTX/N price target is 1,557.49 MXN with a max estimate of 2,175.84 MXN and a min estimate of 1,108.07 MXN. Check if this forecast comes true in a year, meanwhile watch MOONLAKE IMMUNOTHERAPEUTICS stock price chart and keep track of the current situation with MLTX/N news and stock market news.
We've gathered opinions of 15 analysts rating MLTX/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.